Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BPH Canada is a Montreal-based, private clinic specializing in rapid access to advanced treatments for benign prostatic hyperplasia (BPH). Founded by Dr. Kevin Zorn, it is recognized as a Canadian center of excellence for BPH care, offering a comprehensive suite of minimally invasive and surgical therapies, many of which are not covered by public healthcare. The clinic provides personalized, one-stop consultations and diagnostic testing, with a focus on innovative technologies and individualized treatment plans. Clinical results emphasize symptom relief, preservation of sexual function, and efficient recovery, with the clinic actively involved in clinical trials for new BPH therapies and devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BPH Canada Prostate Surgery Institute.